Important: New Login Process
We've updated our access and security system. The first time you log in, enter your work email, and we'll guide you through the process.
- If your organization uses Single Sign-On (SSO), you will be redirected to your company's login portal.
- If you log in with a username and password, you will be prompted to set a new password before accessing your account.
Go to the Login Page to get started.
We appreciate your cooperation during this transition. If you need assistance, please call +1 650-552-4224 or email support@biocentury.com.
- Company Profiles
- Target Profiles
- Product Profiles
Explore BCIQ profiles by entering a company name.
Acadia Pharmaceuticals Inc.
Headquarters: San Diego, CA, United States of America
Website: http://www.acadia-pharm.com
Year Founded: 1993
Status: Public
Industry Sector: HealthTechnology
CEO: Catherine Owen Adams
Number Of Employees: 654
Enterprise Value: $2,348,744,700
PE Ratio: 12.64
Exchange/Ticker 1: NASDAQ:ACAD
Exchange/Ticker 2: N/A
Latest Market Cap: $2,840,416,768
BioCentury | Feb 19, 2025
Deals
Biogen takes territorial rights to Stoke’s Dravet program: Deals Report
Plus: Antithrombotic comes back to Novartis via deal for Anthos, Newleos debuts with portfolio of Roche assets, and more
BioCentury | Jan 23, 2025
Management Tracks
New COOs for Vividion, Edgewise
Plus: Pacira names new heads of commercial, CBO and updates from Vib spinout Tanai, Arcus, Kyverna and Alx
BioCentury | Dec 11, 2024
Management Tracks
Myles Greenberg named president, CEO of InCarda
Plus: Miguel Fernández Alcalde becomes president of EMD Serono, and updates from CorriXR, Acadia and HealthCare Royalty
BioCentury | Dec 3, 2024
Deals
The week in deals: Acadia taps Saniona for GABRA3 modulator, and more
Deals Report: Roche-Poseida, Novartis-PTC and Sarepta-Arrowhead forge large deals, as Idorsia keeps the lights on into 2025
BioCentury | Nov 12, 2024
Deals
GHO, Ampersand to take Avid Bioservices private
BioCentury’s Deals report also includes Karalis’s public path via AlloVir reverse merger, and updates from Oblenio-Leads, Daiichi-Alteogen and Acadia
BioCentury | Nov 6, 2024
Deals
With doubts about voucher program extension, Acadia strikes $150M sale
The deal, among the biggest in years for a priority review voucher, comes weeks after a continuing resolution kept the program alive until December
BioCentury | Sep 24, 2024
Management Tracks
BMS alum Catherine Owen Adams to lead Acadia
Plus: René van der Merwe named CMO of Bambusa, and updates from ModeX and ChromaDex
BioCentury | Jun 12, 2024
Management Tracks
Former Fusion CFO Crowley joins Centessa
Weinhoff becomes CBO. Plus: QurAlis pads C-suite and updates from PepGen, C4 and more
BioCentury | Apr 4, 2024
Management Tracks
Upstream names new CEO, CFO and COO
Plus: Acadia hires Elizabeth Thompson as head of R&D, and updates from Insitro, Fractyl, Adarx and more
Items per page:
1 - 10 of 283